Finally, our results demonstrated that targeted inhibition of BRIX1 by therapeutic exosomes efficiently enhanced 5‐FU chemotherapy and suppressed the growth of colorectal cancer with wild‐type p53 (Figure 7; Figure S5, Supporting Information). This evidence concerns the gene TP53 and colorectal cancer.